Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

CD200 is not a reliable marker for identifying stem cells in all skin types.

Clofazimine may be effective for treating ashy dermatosis.

Monocytes might be linked to hair loss after COVID-19.

The man's hair loss was due to syphilis, and his hair regrew after treatment.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

CT60 polymorphism might increase the risk of Alopecia Areata.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Oral isotretinoin is the most effective treatment for folliculitis decalvans.

COVID-19 may trigger hair loss conditions like alopecia areata.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

circCFAP20DC helps goat ovarian cells grow, aiding follicle development.

The humanized AA mouse model is better for testing new alopecia areata treatments.

CD34 is crucial for skin tumor development in mice.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Rabbits lacking the Hoxc13 gene show similar hair and skin issues to humans with ECTD-9, making them good for research on this condition.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.